Protagenic Therapeutics, Inc.\new Earnings Per Share, Basic and Diluted
Protagenic Therapeutics, Inc.\new (PTIX) reported Earnings Per Share, Basic and Diluted of -$0.31 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-04-07
- Protagenic Therapeutics, Inc.\new earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.05.
- Protagenic Therapeutics, Inc.\new earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.05.
- Protagenic Therapeutics, Inc.\new earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.11.
- Protagenic Therapeutics, Inc.\new earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.11.
- Protagenic Therapeutics, Inc.\new earnings per share, basic and diluted for fiscal 2021 was -$0.31.
- Protagenic Therapeutics, Inc.\new earnings per share, basic and diluted for fiscal 2020 was -$0.25.
- Protagenic Therapeutics, Inc.\new earnings per share, basic and diluted for fiscal 2019 was -$0.17.
- Protagenic Therapeutics, Inc.\new earnings per share, basic and diluted for fiscal 2018 was -$0.25.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.31 10-K · filed 2022-04-07 | |
| 2021-09-30 | -$0.05 10-Q · filed 2021-11-15 | -$0.16 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.26 10-Q · filed 2021-11-15 | -$0.32 derived: net income ÷ weighted average shares · filed 2022-11-14 | |
| 2021-06-30 | -$0.11 10-Q · filed 2021-08-16 | -$0.22 10-Q · filed 2021-08-16 | -$0.28 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.38 derived: net income ÷ weighted average shares · filed 2022-11-14 | |
| 2021-03-31 | -$0.11 10-Q · filed 2021-05-17 | -$0.16 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.27 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.31 derived: net income ÷ weighted average shares · filed 2022-11-14 | |
| 2020-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2022-04-07 | -$0.15 derived: net income ÷ weighted average shares · filed 2022-04-07 | -$0.20 derived: net income ÷ weighted average shares · filed 2022-04-07 | -$0.25 10-K · filed 2022-04-07 | |
| 2020-09-30 | -$0.10 10-Q · filed 2021-11-15 | -$0.15 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.20 10-Q · filed 2021-11-15 | -$0.27 derived: net income ÷ weighted average shares · filed 2021-11-15 | |
| 2020-06-30 | -$0.06 10-Q · filed 2021-08-16 | -$0.10 10-Q · filed 2021-08-16 | -$0.17 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.18 derived: net income ÷ weighted average shares · filed 2021-11-15 | |
| 2020-03-31 | -$0.05 10-Q · filed 2021-05-17 | -$0.12 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.13 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.16 derived: net income ÷ weighted average shares · filed 2021-11-15 | |
| 2019-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$0.09 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$0.11 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$0.17 10-K · filed 2021-03-25 | |
| 2019-09-30 | -$0.01 10-Q · filed 2020-11-16 | -$0.04 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.10 10-Q · filed 2020-11-16 | -$0.17 derived: net income ÷ weighted average shares · filed 2020-11-16 | |
| 2019-06-30 | -$0.03 10-Q · filed 2020-08-14 | -$0.09 10-Q · filed 2020-08-14 | -$0.16 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.21 derived: net income ÷ weighted average shares · filed 2020-11-16 | |
| 2019-03-31 | -$0.06 10-Q · filed 2020-06-18 | -$0.14 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.18 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.25 derived: net income ÷ weighted average shares · filed 2020-11-16 | |
| 2018-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2020-04-29 | -$0.13 derived: net income ÷ weighted average shares · filed 2020-04-29 | -$0.19 derived: net income ÷ weighted average shares · filed 2020-04-29 | -$0.25 10-K · filed 2020-04-29 | |
| 2018-09-30 | -$0.05 10-Q · filed 2019-11-14 | -$0.11 derived: net income ÷ weighted average shares · filed 2019-11-14 | -$0.17 10-Q · filed 2019-11-14 | -$0.24 derived: net income ÷ weighted average shares · filed 2019-11-14 | |
| 2018-06-30 | -$0.07 10-Q · filed 2019-08-14 | -$0.12 10-Q · filed 2019-08-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2019-11-14 | -$0.24 derived: net income ÷ weighted average shares · filed 2019-11-14 | |
| 2018-03-31 | -$0.06 10-Q · filed 2019-05-16 | -$0.13 derived: net income ÷ weighted average shares · filed 2019-11-14 | -$0.17 derived: net income ÷ weighted average shares · filed 2019-11-14 | -$0.21 derived: net income ÷ weighted average shares · filed 2019-11-14 | |
| 2017-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$0.11 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$0.16 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$0.22 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$0.04 10-Q · filed 2018-11-08 | -$0.09 derived: net income ÷ weighted average shares · filed 2018-11-08 | -$0.15 10-Q · filed 2018-11-08 | -$0.21 derived: net income ÷ weighted average shares · filed 2018-11-08 | |
| 2017-06-30 | -$0.04 10-Q · filed 2018-08-14 | -$0.11 10-Q · filed 2018-08-14 | -$0.17 derived: net income ÷ weighted average shares · filed 2018-08-14 | -$0.22 derived: net income ÷ weighted average shares · filed 2018-08-14 | |
| 2017-03-31 | -$0.06 10-Q · filed 2018-05-15 | -$0.12 derived: net income ÷ weighted average shares · filed 2018-05-15 | -$0.18 derived: net income ÷ weighted average shares · filed 2018-05-15 | -$0.25 derived: net income ÷ weighted average shares · filed 2018-05-15 | |
| 2016-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$0.11 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$0.19 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$0.43 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$0.06 10-Q · filed 2017-11-13 | -$0.13 derived: net income ÷ weighted average shares · filed 2017-11-13 | -$0.45 10-Q · filed 2017-11-13 | -$0.02 derived: net income ÷ weighted average shares · filed 2017-11-13 | |
| 2016-06-30 | -$0.08 10-Q · filed 2017-08-08 | -$14.93 10-Q · filed 2016-08-15 | -$0.71 10-Q · filed 2017-08-08 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-08-08 | -$0.02 derived: net income ÷ weighted average shares · filed 2017-08-08 |
| 2016-03-31 | -$52.83 10-Q · filed 2017-05-15 | $0.00 10-Q · filed 2016-07-25 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-05-15 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-05-15 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-05-15 |
| 2015-12-31 | $0.00 10-Q · filed 2016-03-11 | $0.00 10-Q · filed 2016-03-11 | -$0.01 derived: net income ÷ weighted average shares · filed 2016-11-17 | -$0.15 10-K/A · filed 2017-05-08 | |
| 2015-09-30 | -$0.07 10-Q · filed 2016-11-17 | $0.00 10-Q · filed 2015-11-13 | -$0.08 derived: net income ÷ weighted average shares · filed 2016-11-17 | -$0.09 10-Q · filed 2016-11-17 | -$0.01 derived: net income ÷ weighted average shares · filed 2016-11-17 |
| 2015-06-30 | -$0.02 10-Q · filed 2016-08-15 | -$0.02 10-Q · filed 2016-08-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-08-15 | $0.00 10-K · filed 2015-09-25 | |
| 2015-03-31 | -$0.01 10-Q · filed 2016-07-25 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-07-25 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-07-25 | ||
| 2014-12-31 | $0.00 10-Q · filed 2016-03-11 | $0.00 10-Q · filed 2016-03-11 | -$0.05 8-K/A · filed 2016-07-12 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-13 | ||||
| 2014-06-30 | $0.00 10-K · filed 2015-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |